Literature DB >> 11274792

Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

K P Das1, S L Chao, L D White, W T Haines, G J Harry, H A Tilson, S Barone.   

Abstract

The present studies were undertaken to characterize the regional and temporal patterns of neurotrophin messenger RNA and protein levels for beta-nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in the developing CNS. We have examined the levels of these neurotrophin messenger RNAs with ribonuclease protection assays and corresponding protein levels with enzyme-linked immunosorbent assays in the developing Long-Evans rat hippocampus, neocortex and cerebellum on postnatal days 1, 7, 14, 21, and 92. In addition, immunohistochemistry was used to localize the neurotrophins in these developing brain regions. Results indicated that in neocortex and hippocampus, messenger RNA for both nerve growth factor and brain-derived neurotrophic factor increased in an age-dependent manner, reaching a plateau by postnatal day 14. In the neocortex, nerve growth factor and brain-derived neurotrophic factor protein levels both peaked at postnatal day 14. In hippocampus, nerve growth factor protein peaked at postnatal day 7 while brain-derived neurotrophic factor peaked at postnatal day 14. In cerebellum, nerve growth factor messenger RNA levels were flat, while nerve growth factor protein peaked at postnatal day 7. Brain-derived neurotrophic factor messenger RNA increased in an age-dependent manner while the pattern for its protein levels was mixed. Neurotrophin-3 messeger RNA levels increased in an age-dependent manner in hippocampus, peaked at postnatal day14 in cerebellum, and no changes occurred in neocortex. Neurotrophin-3 protein was at its peak at postnatal day 1 and thereafter decreased at other postnatal days in all three brain regions. Results of neurotrophin immunohistochemistry often paralleled and complemented enzyme-linked immunosorbent assay data, demonstrating specific cell groups containing neurotrophin proteins in these regions. Within each region, patterns with regard to messenger RNA and respective protein levels for each neurotrophin were unique. No consistent relationship between patterns of neurotrophin messenger RNAs and their cognate proteins was observed between regions. The different regional patterns for neurotrophin messengerRNA and protein levels in each brain region indicate that messenger RNA studies of neurotrophin messenger RNA must be augmented by protein determination to fully characterize spatial and temporal neurotrophin distribution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11274792     DOI: 10.1016/s0306-4522(01)00011-2

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  31 in total

1.  Brain-derived neurotrophic factor controls dopamine D3 receptor expression: implications for neurodevelopmental psychiatric disorders.

Authors:  Pierre Sokoloff; Olivier Guillin; Jorge Diaz; Patrick Carroll; Nathalie Griffon
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

2.  Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving.

Authors:  Mikko Airavaara; Charles L Pickens; Anna L Stern; Kristina A Wihbey; Brandon K Harvey; Jennifer M Bossert; Qing-Rong Liu; Barry J Hoffer; Yavin Shaham
Journal:  Addict Biol       Date:  2010-12-23       Impact factor: 4.280

3.  Effects of repeated minimal electroshock seizures on NGF, BDNF and FGF-2 protein in the rat brain during postnatal development.

Authors:  Jinsook Kim; Karen Gale; Alexei Kondratyev
Journal:  Int J Dev Neurosci       Date:  2010-02-17       Impact factor: 2.457

4.  Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures.

Authors:  Virginia L Smith-Swintosky; Illana Gozes; Douglas E Brenneman; Michael R D'Andrea; Carlos R Plata-Salaman
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

5.  Regional differences in neurotrophin availability regulate selective expression of VGF in the developing limbic cortex.

Authors:  K L Eagleson; L D Fairfull; S R Salton; P Levitt
Journal:  J Neurosci       Date:  2001-12-01       Impact factor: 6.167

6.  Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze.

Authors:  Michael T Williams; Mary S Moran; Charles V Vorhees
Journal:  Psychopharmacology (Berl)       Date:  2003-04-09       Impact factor: 4.530

7.  (+)-Methamphetamine increases corticosterone in plasma and BDNF in brain more than forced swim or isolation in neonatal rats.

Authors:  Curtis E Grace; Tori L Schaefer; Nicole R Herring; Matthew R Skelton; Anne E McCrea; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2008-02       Impact factor: 2.562

Review 8.  Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility.

Authors:  Tetsushi Sadakata; Teiichi Furuichi
Journal:  Cerebellum       Date:  2009-02-24       Impact factor: 3.847

9.  Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism.

Authors:  Elizabeth M Sajdel-Sulkowska; Ming Xu; Noriyuki Koibuchi
Journal:  Cerebellum       Date:  2009-04-09       Impact factor: 3.847

10.  Influence of brain-derived neurotrophic factor on pathfinding of dentate granule cell axons, the hippocampal mossy fibers.

Authors:  Makoto Tamura; Naohiro Tamura; Takamitsu Ikeda; Ryuta Koyama; Yuji Ikegaya; Norio Matsuki; Maki K Yamada
Journal:  Mol Brain       Date:  2009-01-31       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.